Nasdaq:US$16.21 (-0.64) | HKEX:HK$26.45 (+1.00) | AIM:£2.72 (+0.05)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 2 Jul 2007

Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis

1 items
a070702